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Objectives The purpose of this study was to test the hypothesis that severity of sleep apnea (SA), assessed by frequency of
apneas and hypopneas per hour of sleep (apnea-hypopnea index [AHI]), is related to sodium intake in patients
with heart failure (HF).
Background Dependent edema and overnight rostral fluid shift from the legs correlate with the AHI in patients with HF in
whom excessive sodium intake can cause fluid retention.
Methods Sodium intake was estimated by food recordings in 54 HF patients who underwent overnight polysomnography.
Results Thirty-one of the 54 patients had SA, and their mean sodium intake was higher than that in those without SA
(3.0  1.2 g vs. 1.9  0.8 g, p  0.001). There was a significant correlation between the AHI and sodium intake
(r  0.522, p  0.001). Multivariate analysis showed that the significant independent correlates of the AHI were
sodium intake, male sex, and serum creatinine level.
Conclusions These findings suggest that in patients with HF, sodium intake plays a role in the pathogenesis of SA. (J Am
Coll Cardiol 2011;58:1970–4) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.08.012Sleep apnea (SA), including obstructive sleep apnea (OSA)
and central sleep apnea (CSA), occurs in approximately 50%
of patients with heart failure (HF), in whom it is associated
with increased mortality (1–3). The observation that OSA is
more prevalent in patients with edematous states, such as
HF, than in the general population, despite lower body
weight (1,4,5), raises the possibility that fluid retention may
increase the risk for OSA. A recent study suggested that
fluid retained in the legs during the day could shift rostrally
into the neck when recumbent during sleep, causing pe-
ripharyngeal fluid accumulation and upper airway narrow-
ing, thereby predisposing such persons to OSA (6).
CSA also is common in HF patients (1) and is caused by
a tendency to hyperventilate resulting from increased
chemoreceptor responsiveness and from pulmonary conges-
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accepted August 15, 2011.tion that induces a fall in partial pressure of carbon dioxide
below the apnea threshold (7). In HF patients, the degree of
overnight rostral fluid displacement from the legs is in-
versely proportional to partial pressure of carbon dioxide
during sleep and is directly related to the severity of CSA,
suggesting that some of this fluid is redistributed into the
lungs (6). Because fluid retention in the legs in the daytime
contributes to rostral redistribution of fluid into the neck
and lungs at night, it seems likely that high sodium intake,
which can cause fluid retention in HF patients, may play a
role in the pathogenesis of both OSA and CSA.
Sodium retention, a hallmark of HF, causes excessive
fluid accumulation (8,9). Indeed, we recently demonstrated
that high sodium intake is associated with an increased risk
of HF exacerbations (10). We therefore tested the hypoth-
esis that in HF patients, sodium intake is related to the
severity of SA.
Methods
Subjects. Subjects for this study were originally enrolled in
our previous study between 2003 and 2007 (10). Inclusion
criteria were HF patients 18 to 85 years of age with left
ventricular ejection fraction (LVEF) 35%, with stable
medical condition for 3 months or more, and receiving
optimal medical HF therapy. Exclusion criteria were a
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November 1, 2011:1970–4 Sodium Intake and Sleep Apnea in Heart Failureserum creatinine level of 140 mmol/l and a serum sodium
evel of 130 mmol/l. Patients consumed a self-selected
iet. Among 123 patients enrolled in the original study, 57
46%) underwent overnight polysomnography as a part of
n epidemiological study (n  45) (1) or as a part of
creening for a clinical trial (n 12) (11). Among them, we
excluded 3 patients who had been hospitalized for HF
during the interval between dietary assessment and poly-
somnography, because this may have affected sodium intake.
All polysomnograms were obtained within 3 years before or
6 months after the assessment of sodium intake (mean
interval: 14.6 months). Demographic characteristics, med-
ications, LVEF, estimated glomerular filtration rate
(eGFR), and serum sodium were recorded before the
assessment of sodium intake. The study was approved by the
local research ethics board, and all subjects provided written
informed consent before enrollment.
Assessment of sodium intake. Sodium intake was assessed
by 2 3-day food recordings: one at study entry and a second
6 to 12 weeks later. Mean values were used to estimate
habitual intake of sodium and other nutrients. This is a valid
method to assess dietary intake in HF patients (12) and to
capture individual day-to-day variation in sodium consump-
tion (13,14). Further details of this dietary assessment were
described previously (10,12).
Polysomnography. Subjects underwent overnight in-
laboratory polysomnography using standard techniques and
scoring criteria for sleep stages and arousals from sleep and
obstructive and central apneas and hypopneas, as previously
described (1,15,16). Severity of SA was assessed by the
frequency of apneas and hypopneas per hour of sleep
(apnea-hypopnea index [AHI]). For purposes of this study,
subjects were divided into an SA group (AHI 15) and a
non-SA group (AHI 15) (1,17) and also into an
obstructive-dominant group (i.e., 50% obstructive events)
and a central-dominant group (i.e., 50% central events).
Statistical analysis. Patient characteristics and dietary in-
take were compared between the non-SA and SA groups
using the t test or Mann–Whitney U test for continuous
ariables and the chi-square or Fisher exact test for categor-
cal variables. The best cutoff value for sodium intake
redicting the presence of SA was identified by receiver
perating characteristic curve at regular intervals as the value
hat minimized the expression ([1  sensitivity]2  [1 
specificity]2). Univariate correlations between AHI and
other variables were analyzed. Because the latency between
the dietary assessment and polysomnography was long,
interactions between the latency period and the correlation
between AHI and sodium intake were assessed. Stepwise
multiple regression analysis with AHI as the dependent
variable and age, sex, body mass index (BMI), use of
medications, eGFR, LVEF, and calorie, fluid, potassium,
and sodium intake as independent variables was performed.
Similar univariate and multiple regression analyses also were
performed in the obstructive-dominant and central-dominant subgroups. A p value
0.05 indicated statistical
significance.
Results
Subject characteristics. Of 54
patients, 23 (43%) were in the
non-SA group and 31 (57%)
were in the SA group (Table 1).
Patients with SA were more
likely to be male than those with-
out SA. A lower percentage of
the SA group was receiving furo-
semide than those in the non-SA
group, whereas a higher percent-
age of the SA group was receiv-
ing spironolactone than those in
the non-SA group. The SA
group had greater fluid, potassium, protein, and total calorie
intake than the non-SA group (Table 2), but there was no
significant difference in BMI between them. By definition,
the AHI was greater in the SA group than in the non-SA
group (Table 3). Compared with the non-SA group, ob-
structive and central AHIs were higher, minimum arterial
oxyhemoglobin saturation was lower, and the arousal index
was higher in the SA group.
Characteristics of the SubjectsTable 1 Characteristics of the Subjects
No Sleep Apnea
AHI <15/h
(n  23)
Sleep Apnea
AHI >15/h
(n  31) p Value
Age, yrs 55 15 62 10 0.085
Male 10 (44) 28 (90.3) 0.001
BMI, kg/m2 30.4 5.3 30.7 5.7 0.865
NYHA functional class I to II 15 (65) 20 (65) 0.957
NYHA functional class III to IV 8 (35) 11 (35)
LVEF, % 25 9 26 9 0.873
Systolic BP, mm Hg 116 15 119 17 0.584
Diastolic BP, mm Hg* 70 [10] 70 [10] 0.542
Heart rate, beats/min 71 13 73 16 0.619
Serum sodium, mmol 139 2 139 3 0.328
eGFR, ml/min/1.73 m2 78.9 23.8 68.2 18.4 0.069
Coronary artery disease 8 (35) 13 (42) 0.594
Diabetes 7 (30) 11 (36) 0.697
Hypertension 6 (26) 12 (39) 0.331
Smoker 2 (9) 5 (16) 0.685
Medications
Furosemide 22 (96) 22 (71) 0.021
Spironolactone 7 (30) 18 (58) 0.044
Beta-blocker 20 (87) 28 (90) 1.000
ACE-I/ARB 22 (96) 30 (97) 1.000
Values are mean  SD, n (%), or median [interquartile range] as appropriate. *Mann–Whitney U
test was used for comparison between groups.
ACE-I  angiotensin-converting enzyme inhibitors; AHI  apnea-hypopnea index; ARB 
angiotensin II receptor blockers; BMI body mass index; BP blood pressure; eGFR estimated
Abbreviations
and Acronyms
AHI  apnea-hypopnea
index
BMI  body mass index
CPAP  continuous
positive airway pressure
CSA  central sleep apnea
eGFR  estimated
glomerular filtration rate
HF  heart failure
LVEF  left ventricular
ejection fraction
OSA  obstructive sleep
apnea
SA  sleep apneaglomerular filtration rate; LVEF  left ventricular ejecti
Association.on fraction; NYHA  New York Heart
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Sodium Intake and Sleep Apnea in Heart Failure November 1, 2011:1970–4Sodium intake and SA. The SA group had significantly
greater sodium intake than the non-SA group (Table 2).
The best cutoff value of sodium intake predicting SA was
more than 2.39 g (area under the curve: 0.78; 95% confi-
dence interval: 0.65 to 0.91; p  0.001; sensitivity: 74.2;
specificity: 78.3).
The AHI correlated significantly with sodium intake
(Fig. 1). The only other significant correlates of the AHI
were calorie intake (coefficient: 0.313; p  0.021) and male
sex (coefficient: 0.522; p  0.001). Multivariate analysis
howed that the only significant independent correlates of
he AHI were male sex, eGFR, and sodium intake, which
ogether accounted for 47% of the variability in the AHI
p  0.001) (Table 4). There was no interaction between
he latency period between dietary assessments and poly-
omnography (over vs. under the mean value) and the
orrelation between AHI and sodium intake (p  0.630).
In the obstructive-dominant group (n  35), there were
etter correlations between AHI and sodium intake (r 
.565; p  0.001) than for the entire group, and multivar-
ate analysis showed that the only significant independent
orrelates of the AHI were male sex, BMI, and sodium
ntake (Table 5). In the central-dominant group (n  19),
Dietary IntakeTable 2 Dietary Intake
No Sleep Apnea
AHI <15/h
(n  23)
Sleep Apnea
AHI >15/h
(n  31) p Value
Calories, kcal/day 1,758 604 2,152 537 0.017
Carbohydrate, g/day 222 82 266 88 0.069
Protein, g/day 82 26 106 26 0.001
Fat, g/day 59 28 73 25 0.072
Fluid, ml/day 1,923 471 2,404 956 0.031
Ethanol, g/day* 2.9 [4.6] 0 [12.4] 0.589
Potassium, g/day 2.9 0.9 3.4 1.0 0.045
Sodium, g/day 1.9 0.8 3.0 1.2 0.001
Values are mean SD or median [interquartile range] as appropriate. *Mann–Whitney U test was
sed for comparison between groups.
AHI  apnea-hypopnea index.
Sleep Study DataTable 3 Sleep Study Data
No Sleep Apnea
AHI <15/h
(n  23)
Sleep Apnea
AHI >15/h
(n  31) p Value
Total AHI, n/h of sleep 7.7 3.6 38.2 18.6 0.001
Obstructive AHI, n/h of sleep 5.9 4.3 21.7 20.3 0.001
Central AHI, n/h of sleep* 0.4 [2.7] 11.9 [30.8] 0.001
Mean SaO2, % 94.9 1.9 94.4 1.9 0.331
Minimum SaO2, % 86.7 3.8 81.9 10.3 0.038
Total sleep time, min 314.7 74.7 300.7 54.7 0.430
Slow wave sleep, %TST 13.1 9.0 9.0 7.9 0.078
REM sleep, %TST 16.1 5.4 15.8 7.2 0.862
Arousal index, no./h of
sleep*
12.4 [9.0] 27.6 [13.0] 0.001
Values are mean  SD or median [interquartile range]. *Mann–Whitney U test was used for
omparison between groups.
AHI  apnea-hypopnea index; REM  rapid eye movement; SaO2  arterial oxyhemoglobin
aturation; %TST  percentage of total sleep time.here was only a nonsignificant tendency for the AHI to
orrelate with sodium intake (r  0.422; p  0.072), but
ultivariate analysis showed that significant independent
orrelates of the AHI were BMI, LVEF, and sodium intake
Table 6).
iscussion
ur findings provide novel insights into the pathogenesis of
A in patients with HF. First, we found that the AHI was
elated independently to sodium intake. Second, we found
n inverse relationship between AHI and eGFR. Our
ndings therefore suggest that high sodium intake and
mpaired renal function increase the odds for SA in patients
ith HF.
Among HF patients, excessive sodium intake, renal
ysfunction, or both can cause sodium and fluid retention
8,9), whereas fluid distribution is influenced by posture.
hile sitting, gravity sequesters fluid in the legs (18). In
F, elevated venous pressure further contributes to leg
dema (19). Therefore, HF patients with excessive sodium
ntake, renal dysfunction, or both are prone to accumulate
Figure 1 Correlation Between Sodium Intake and AHI
Graph showing the correlation between sodium intake and
apnea-hypopnea index (AHI).
Factors Independently Related to theApnea-Hypopn a IndexTable 4 Factors Independently Related to theApnea-Hypopnea Index
Partial Correlation Coefficient p Value
Male 0.444 0.001
eGFR –0.374 0.006
Sodium intake/day 0.522 0.001
Multiple Correlation Coefficient
Total model 0.687 0.001
Independent variables included in this multivariate analysis included age, sex, body mass index,
angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker use, beta blocker use,
furosemide use, spironolactone use, estimated glomerular filtration rate, left ventricular ejection
fraction, calorie intake, fluid intake, potassium intake, and sodium intake.
eGFR  estimated glomerular filtration rate.
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November 1, 2011:1970–4 Sodium Intake and Sleep Apnea in Heart Failurefluid in their legs. Our recent study showed that the severity
of both OSA and CSA in men with HF is strongly related
to the amount of fluid displaced rostrally from the legs
overnight (6). The amount of this overnight fluid displace-
ment in turn was related directly to the amount of time
spent sitting during the daytime and the degree of leg
edema. Therefore, high sodium intake and renal dysfunc-
tion likely contributed to SA severity at least partially
through fluid retention and increased overnight rostral fluid
displacement. Because fluid retention in the legs during the
daytime contributes to overnight rostral fluid redistribution
to the neck and lungs, it is probable that high sodium intake
and renal dysfunction contribute to the pathogenesis of
OSA and CSA in HF patients. The observation that
sodium intake correlated independently with the AHI in
both the obstructive-dominant and central-dominant
groups favors this possibility.
In terms of the appropriate level of sodium intake for
patients with HF, there is some controversy. Our previous
study suggested that the upper limit of sodium intake for
HF patients should be similar to that recommended for
healthy adults, that is, 2.3 g/day (10). Interestingly, this
value is practically identical to the best cutoff value of
sodium intake that predicted the presence of SA in the
present study. Previous data showed that the presence of SA
in HF patients is associated with increased mortality risk
(2,3). Because high sodium intake is associated with the
presence of SA in HF patients, there may be an interaction
between sodium intake and SA that increases the risk of
adverse cardiovascular events, possibly via fluid retention. In
this context, limitation of sodium intake may be beneficial
to HF patients either directly by alleviating pulmonary
congestion, or indirectly by alleviating SA and its related
adverse effects.
Study limitations. First, because it was observational, the
esults do not prove a cause-and-effect relationship between
odium intake and SA. One way to determine whether there
s a cause-and-effect relationship between sodium intake
nd sleep apnea would be through a trial of sodium
estriction. However, such a trial would not be warranted
nless we found a relationship between sodium intake and
A severity. Second, the ability to control for confounders
ay be limited by the sample size. Third, we did not directly
Factors Independently Relatedto the Apnea-Hypopnea Index in theObs ructiv -Domina t Group (n  35)
Table 5
Fact rs Independe tly Related
to the Apnea-Hypopnea Index in the
Obstructive-Dominant Group (n  35)
Partial Correlation Coefficient p Value
Male 0.477 0.005
BMI 0.396 0.022
Sodium intake/day 0.364 0.037
Multiple Correlation Coefficient
Total model 0.723 0.001The same variables described in Table 4 were included.
BMI  body mass index.measure the degree of fluid retention and overnight fluid
redistribution related to sodium intake. It therefore is
possible that other unmeasured factors also might have
affected the relationship between sodium intake and SA.
Fourth, we did not assess B-type natriuretic peptide con-
centration, a marker of cardiac volume overload. Finally,
during the interval between polysomnography and assess-
ment of sodium intake, the amount of sodium intake could
have changed. However, the lack of any interaction between
this interval and relationship between sodium intake and
AHI suggests that this latency did not affect the results of
the relationship between sodium intake and AHI.
Conclusions
We have shown that in HF patients, the severity of SA is
related directly to dietary sodium intake and is inversely
related to renal function. It is likely that this association is
the result of fluid retention secondary to the combined
effects of high sodium intake and impaired renal function
and to overnight rostral fluid shift from the legs. High
sodium intake therefore may play a role in the pathogenesis
of SA in HF patients. If so, modulation of sodium intake
may be a therapeutic strategy to alleviate SA in HF.
Consequently, studies assessing fluid volume and overnight
fluid shift and their relationships to both sodium intake and
severity of SA, as well as interventional studies to assess the
effect of reduced sodium intake on fluid volume and severity
of SA, will be required to test our hypotheses.
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